Bridging
innovation
Solvian
Solvian
Rare Diseases
Patient Access
Solvian Therapeutics is a specialty pharmaceutical company dedicated to improving access to innovative therapies for children living with rare and underserved diseases. Our focus is on identifying, representing, and commercializing high-value treatments for rare pediatric conditions, with particular expertise in orphan diseases, complex neurological disorders, genetic diseases, and other specialized therapeutic areas where significant unmet medical needs remain.
A core pillar of the company is the development and management of Patient Access Programs (PAPs) designed to support treatment initiation, continuity of care, affordability, and adherence. These programs may include early access initiatives, named-patient supply, compassionate use support, patient education, and treatment coordination services.